Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice
Open Access
- 16 June 2015
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 9, 157
Abstract
L-Kynurenine (L-KYN) is a central metabolite of tryptophan degradation through the kynurenine pathway (KP). The systemic administration of L-KYN sulfate (L-KYNs) leads to a rapid elevation of the neuroactive KP metabolite kynurenic acid (KYNA). An elevated level of KYNA may have multiple effects on the synaptic transmission, resulting in complex behavioral changes, such as hypoactivity or spatial working memory deficits. These results emerged from studies that focused on rats, after low-dose L-KYNs treatment. However, in several studies neuroprotection was achieved through the administration of high-dose L-KYNs.In the present study, our aim was to investigate whether the systemic administration of a high dose of L-KYNs (300 mg/bwkg; i. p.) would produce alterations in behavioral tasks (open field or object recognition) in C57Bl/6j mice. To evaluate the changes in neuronal activity after L-KYNs treatment, in a separate group of animals we estimated c-Fos expression levels in the corresponding subcortical brain areas. The L-KYNs treatment did not affect the general ambulatory activity of C57Bl/6j mice, whereas it altered their moving patterns, elevating the movement velocity and resting time. Additionally, it seemed to increase anxiety-like behavior, as peripheral zone preference of the open field arena emerged and the rearing activity was attenuated. The treatment also completely abolished the formation of object recognition memory and resulted in decreases in the number of c-Fos-immunopositive-cells in the dorsal part of the striatum and in the CA1 pyramidal cell layer of the hippocampus.We conclude that a single exposure to L-KYNs leads to behavioral disturbances, which might be related to the altered basal c-Fos protein expression in C57Bl/6j mice.Keywords
This publication has 94 references indexed in Scilit:
- Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantaminePsychopharmacology, 2011
- Targeting the kynurenine pathway as a potential strategy to prevent and treat Alzheimer’s diseaseMedical Hypotheses, 2011
- Influence of Pre-Training Predator Stress on the Expression of c-fos mRNA in the Hippocampus, Amygdala, and Striatum Following Long-Term Spatial Memory RetrievalFrontiers in Behavioral Neuroscience, 2011
- Centrality of Striatal Cholinergic Transmission in Basal Ganglia FunctionFrontiers in Neuroanatomy, 2011
- Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With SchizophreniaSchizophrenia Bulletin, 2010
- Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in SchizophreniaSchizophrenia Bulletin, 2010
- Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecidNeuroscience Letters, 2007
- Elevations of Endogenous Kynurenic Acid Produce Spatial Working Memory DeficitsSchizophrenia Bulletin, 2007
- The use of the elevated plus maze as an assay of anxiety-related behavior in rodentsNature Protocols, 2007
- Kynurenic acid has a dual action on AMPA receptor responsesNeuroscience Letters, 2006